As Lentiviral vectors have transformed medicine with their safety and efficacy, they have created a demand for production that far exceeds current capacity.

Traditional manufacturing systems have seen long wait times and critical raw material shortages cause delays in development and deployment of these life-altering therapies.

Our Intelligent Vector Solutions(TM) can be used to manufacture ANY LENTI, ANY SCALE(TM) to provide our clients an END TO END solution, speeding their development and securing their supply chain.

Biotechnology

iVexSol

Rodney L. Rietze

Lauren Revene

Andrew Lussier

Amha Mulaw

Matthew Gay

Mary Schier

Heather Puksta

Vikram Sarveiya

Scientific Research Team

Teams at iVexSol

Scientific Research Team